RBMS3 and neoplasm: RBMS3, a RNA-binding protein with tumor-suppressing functions, shows reduced expression in epithelial ovarian cancer (EOC), and this decrease is linked to poorer outcomes for patients, such as shorter overall survival and progression-free survival (147).